Reactive Human CD 8 T Cells that Recognize an Epitope Conserved between VZV , HSV and EBV
暂无分享,去创建一个
M. Carrington | B. Pulendran | Bjoern Peters | J. Sidney | A. Sette | F. Duh | A. Mehta | M. McCausland | R. Ahmed | M. Mulligan | M. Levin | N. Rouphael | C. Chiu | A. Weinberg | A. Wieland | N. Sullivan | M. Mccausland | Nicole L Sullivan
[1] I. Papassotiriou,et al. Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] Lawrence Corey,et al. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection , 2013, Nature Medicine.
[3] J. Haas,et al. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. , 2012, The Journal of clinical investigation.
[4] J. Sidney,et al. Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses , 2012, Clinical and experimental immunology.
[5] E. Wherry,et al. Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. , 2012, Current Opinion in HIV and AIDS.
[6] J. Breuer,et al. Molecular studies of the Oka varicella vaccine , 2011, Expert review of vaccines.
[7] M. Oxman. Zoster vaccine: current status and future prospects. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] M. Levin,et al. VZV T cell-mediated immunity. , 2010, Current topics in microbiology and immunology.
[9] P. Kinchington,et al. Varicella zoster virus immune evasion strategies. , 2010, Current topics in microbiology and immunology.
[10] G. Pantaleo,et al. Distinct Profiles of Cytotoxic Granules in Memory CD8 T Cells Correlate with Function, Differentiation Stage, and Antigen Exposure , 2009, Journal of Virology.
[11] M. Ressing,et al. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. , 2008, Seminars in cancer biology.
[12] M. Levin,et al. Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine. , 2007, Vaccine.
[13] M. Ressing,et al. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates , 2007, The Journal of experimental medicine.
[14] J. Stockman. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults , 2007 .
[15] Philip J. R. Goulder,et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.
[16] Sang-Jun Ha,et al. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. , 2006, Journal of immunology.
[17] G. Freeman,et al. Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.
[18] Bagher Forghani,et al. Stress‐induced subclinical reactivation of varicella zoster virus in astronauts , 2004, Journal of medical virology.
[19] V. Loparev,et al. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. , 2003, The Journal of infectious diseases.
[20] A. Wald,et al. T Cell Immunity to Herpes Simplex Viruses in Seronegative Subjects: Silent Infection or Acquired Immunity?1 , 2003, The Journal of Immunology.
[21] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[22] A. Arvin. Immune responses to varicella-zoster virus. , 1996, Infectious disease clinics of North America.
[23] J. Yewdell,et al. Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.
[24] M. Levin,et al. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. , 1994, The Journal of infectious diseases.
[25] J. Cohen,et al. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro , 1994, Journal of virology.
[26] M. Levin,et al. Immune response of elderly individuals to a live attenuated varicella vaccine. , 1992, The Journal of infectious diseases.
[27] A. Arvin,et al. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. , 1992, The Journal of infectious diseases.
[28] S. Weller,et al. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. , 1989, Virology.
[29] E. Hunter,et al. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. , 1989, Journal of Immunology.
[30] R. Good,et al. Disturbances in gamma globulin synthesis as experiments of nature. , 1956, Pediatrics.